Related references
Note: Only part of the references are listed.Detection of pre-neoplastic and neoplastic prostate disease by MADI profiling of urine
Amosy E. M'Koma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Prevention of benign prostatic hyperplasia disease
Leonard S. Marks et al.
JOURNAL OF UROLOGY (2006)
Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry
Masaya Ono et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Prognostic significance of osteopontin expression in human prostate cancer
SS Forootan et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Concanavalin A-captured glycoproteins in healthy human urine
LJ Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Human urine proteome analysis by three separation approaches
W Sun et al.
PROTEOMICS (2005)
Towards characterization of the human urinary peptidome
M Jürgens et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Exploring the hidden human urinary proteome via ligand library beads
A Castagna et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Development of a high-throughput method for preparing human urine for two-dimensional electrophoresis
G Smith et al.
PROTEOMICS (2005)
Prospects for urinary proteomics: Exosomes as a source of urinary biomarkers
EJ Hoorn et al.
NEPHROLOGY (2005)
Beyond quantitative proteomics: Signal enhancement of the a(1) ion as a mass tag for peptide sequencing using dimethyl labeling
JL Hsu et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots
R Pieper et al.
PROTEOMICS (2004)
Identification and proteomic profiling of exosomes in human urine
T Pisitkun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Establishment of a near-standard two-dimensional human urine proteomic map
J Oh et al.
PROTEOMICS (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Stable-isotope dimethyl labeling for quantitative proteomics
JL Hsu et al.
ANALYTICAL CHEMISTRY (2003)
Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), α-1-antichymotrypsin (ACT), and the PSA-ACT complex
XS Wan et al.
PROSTATE (2003)
Advances in quantitative proteomics via stable isotope tagging and mass spectrometry
WA Tao et al.
CURRENT OPINION IN BIOTECHNOLOGY (2003)
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma
RD Unwin et al.
PROTEOMICS (2003)
Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation
V Thongboonkerd et al.
KIDNEY INTERNATIONAL (2002)
Prostate specific antigen complexed to α-1-antichymotrypsin in patients with intermediate prostate specific antigen levels
T Saika et al.
CANCER (2002)
Biomarker discovery in urine by proteomics
JX Pang et al.
JOURNAL OF PROTEOME RESEARCH (2002)
Share Paper
